What are the major classes of diuretics and the typical adult agents with their usual dosing?

Major Classes of Diuretics and Typical Adult Dosing

The three major classes of diuretics used in clinical practice are loop diuretics, thiazide-type diuretics, and potassium-sparing diuretics (including mineralocorticoid receptor antagonists), each with distinct mechanisms of action and clinical applications.

Loop Diuretics

Loop diuretics are the preferred agents for most patients with heart failure and significant fluid overload, acting at the loop of Henle to produce intense but shorter-duration diuresis 1.

Common agents and dosing:

• Furosemide

  • Outpatient: 20-80 mg orally once to twice daily (maximum 600 mg/day)
  • Inpatient: 40-160 mg IV once to 3 times daily (maximum 200 mg/dose) or 5-20 mg/hour IV infusion (maximum 40 mg/hour)
  • Duration of action: 6-8 hours 1, 2

• Bumetanide

  • Outpatient: 0.5-2 mg orally once to twice daily (maximum 10 mg/day)
  • Inpatient: 0.5-4 mg IV once to 3 times daily (maximum 5 mg/dose) or 0.5-2 mg/hour IV infusion (maximum 4 mg/hour)
  • Duration of action: 4-6 hours 1, 2

• Torsemide

  • Outpatient: 10-40 mg orally once daily (maximum 200 mg/day)
  • No IV formulation available in the United States
  • Duration of action: 12-16 hours 1, 2

Key clinical point: For patients already on loop diuretics prior to admission, convert the oral dose to an IV dose of 1-2.5 times the home dose. For diuretic-naïve patients, start at the lower end of the dosing range 1.

Thiazide-Type Diuretics

Thiazide and thiazide-like diuretics act in the distal convoluted tubule and are preferred for hypertension management and mild fluid retention 3, 2. They are less effective than loop diuretics in patients with moderate-to-severe chronic kidney disease (GFR <30 mL/min) 4.

Common agents and dosing:

• Hydrochlorothiazide

  • Outpatient: 25-50 mg orally once daily (maximum 100 mg/day)
  • Inpatient: 25-50 mg orally once to twice daily (maximum 100 mg/day)
  • Duration of action: 6-12 hours 1, 2

• Chlorthalidone (preferred over hydrochlorothiazide due to longer half-life and superior cardiovascular outcomes 4)

  • Outpatient: 25-50 mg orally once daily (maximum 100 mg/day)
  • Inpatient: 12.5-25 mg orally once to twice daily (maximum 100 mg/day)
  • Duration of action: 24-72 hours 1, 2

• Metolazone

  • Outpatient: 2.5-5 mg orally once daily (maximum 20 mg/day)
  • Inpatient: 2.5-5 mg orally once to twice daily (maximum 20 mg/day)
  • Duration of action: 12-24 hours 1, 2

• Chlorothiazide (only IV thiazide available)

  • Inpatient: 0.5-1 g IV once to twice daily (maximum 2 g/day)
  • Duration of action: 6-12 hours 1, 2

• Indapamide

  • Outpatient: 2.5 mg orally once daily (maximum 5 mg/day)
  • Duration of action: 36 hours 3, 2

Important caveat: Metolazone and chlorothiazide can be combined with loop diuretics for sequential nephron blockade in patients with refractory edema, but this combination requires close monitoring for electrolyte depletion and renal dysfunction 1, 2.

Potassium-Sparing Diuretics

These agents act in the distal tubule and collecting duct, either by blocking aldosterone receptors or epithelial sodium channels 3, 2.

Mineralocorticoid receptor antagonists (preferred for heart failure):

• Spironolactone

  • Starting dose: 12.5-25 mg orally once daily (maximum 50 mg/day for heart failure; up to 100 mg/day for hypertension)
  • Duration of action: 1-3 hours (but effects persist longer) 3, 2, 4

• Eplerenone

  • Starting dose: 25 mg orally once daily (maximum 50 mg/day for heart failure; up to 100 mg/day for hypertension, often requiring twice-daily dosing)
  • Preferred over spironolactone when gynecomastia is a concern 4

Epithelial sodium channel blockers (minimally effective as monotherapy):

• Amiloride

  • Starting dose: 5 mg orally once daily (maximum 20 mg/day)
  • Duration of action: 24 hours 3, 2

• Triamterene

  • Starting dose: 50-75 mg orally twice daily (maximum 200 mg/day)
  • Duration of action: 7-9 hours 3, 2

Critical safety warning: Do not combine different potassium-sparing diuretics (e.g., spironolactone with amiloride) due to severe hyperkalemia risk. Avoid in patients with significant chronic kidney disease (GFR <45 mL/min for amiloride/triamterene; monitor closely with GFR <60 mL/min for MRAs) 3, 4.

Practical Considerations

Monitoring requirements: All patients on diuretics require regular monitoring of electrolytes (particularly potassium, sodium, magnesium), renal function (creatinine, BUN), and daily weights 1. During hospitalization, check electrolytes at least daily 1.

Diuretic resistance strategies: When patients become unresponsive to standard loop diuretic doses, options include: (1) dose escalation, (2) switching from oral to IV administration, (3) continuous IV infusion rather than bolus dosing, or (4) adding a thiazide or thiazide-like diuretic for sequential nephron blockade 1, 5.

Common pitfalls: Excessive diuretic dosing leads to volume contraction, hypotension, and renal insufficiency. Conversely, inadequate dosing results in persistent fluid retention that undermines other heart failure therapies 2, 5. The goal is to achieve and maintain euvolemia with the lowest effective dose 3, 5.